New at-home test can detect multiple respiratory infections in children and adults.
- First FDA-cleared 4-in-1 home test available in the U.S.
- Quick results for RSV, flu, and COVID-19 detection.
- Designed for individuals aged six months and older.
Flowflex has introduced the first FDA-cleared at-home test that detects respiratory syncytial virus (RSV), influenza, and COVID-19 in individuals aged six months and older. This test represents a significant advancement in home testing for respiratory infections, enabling users to receive comprehensive results conveniently from their homes. It can identify multiple infections with a single test, which is particularly valuable during respiratory illness season.
The 4-in-1 test provides rapid results within 15 minutes, allowing users to quickly understand their health status. This is particularly important as flu season coincides with the ongoing challenge of COVID-19. The test's design is user-friendly, making it accessible for families, including those with young children.
This new home testing option aligns with the increasing demand for at-home health solutions that facilitate early detection of illnesses. As respiratory infections continue to pose public health challenges, the FDA clearance of this multi-disease test emphasizes the importance of home diagnostics in managing and controlling outbreaks.
